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Detection of subclinical synovitis in patients with rheumatoid arthritis in clinical remission
KY Yuen1, LS Wong2, KP Wu2, SW Wong2, MY Mok1, WS Wong1
1Department of Medicine, Queen Mary Hospital, Hong Kong
2Department of Radiology, Queen Mary Hospital, Hong Kong
Objectives: To detect the prevalence of subclinical synovitis in patients with rheumatoid arthritis (RA) in clinical 
remission by musculoskeletal ultrasonography (USG) and to define possible predictors for the presence of subclinical 
synovitis.
Methods: A total of 37 RA patients receiving disease-modifying anti-rheumatic drugs (DMARDs) with disease 
in clinical remission were recruited. They were subject to clinical, laboratory, functional status or quality-of-
life and radiographic evaluation at baseline. Disease Activity Score 28-joint assessment (DAS-28) was calculated. 
Musculoskeletal USG including both grey-scale and power Doppler techniques to the dorsal aspect of both wrists and 
all metacarpophalangeal joints was performed on each subject.
Results: Of 37 RA patients with clinical remission, nine were found to have increased power Doppler signal by USG, 
signifying the presence of subclinical synovitis, the prevalence rate being 24.3%. The continuous DAS-28 with three 
variables version using C-reactive protein (DAS-28 CRP v3) was the only independent predictor for the presence of 
USG-detected subclinical synovitis in the multivariate analysis with the odds ratio (OR) of 8.158, P=0.052. The cut-off 
value of DAS-28 CRP v3 was found to be 2.32 with the sensitivity of 66.7% and specificity of 78.6% for the presence 
of USG-detected subclinical synovitis.
Conclusion: Musculoskeletal USG is more sensitive than clinical assessment to detect subclinical synovitis. USG with 
grey-scale and power Doppler in combination with clinical assessment allows more accurate evaluation of the disease 
status, especially for the definition of true remission. DAS-28 CRP v3 may be used as a guide to stratify those relatively 
higher-risk stable RA patients for proceeding to musculoskeletal USG examination to delineate the true disease status 
and to optimise maintenance therapy.
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High-sensitivity C-reactive protein and other inflammatory markers in predicting  
cardiovascular risk in Hong Kong Chinese
MAM Yuen, AWK Tso, BMY Cheung, LSC Law, SV Lo, WS Chow, KSL Lam
Department of Medicine, Queen Mary Hospital, and the Hospital Authority, Hong Kong
introduction: Inflammation is increasingly recognised as a key player in atherosclerosis, and C-reactive protein 
measured using high-sensitivity assay (hsCRP) is the most promising inflammatory marker in predicting the risk of 
cardiovascular diseases (CVD). In this prospective cohort study, we examined the predictive value of hsCRP for CVD in 
Hong Kong Chinese and determined if other biomarkers would enhance the predictive value of hsCRP.
Methods: Subjects were recruited from the Hong Kong Cardiovascular Risk Factors Prevalence Study 2 (CRISPS-2) 
cohort. Those with known cardiovascular disease(s) were excluded. Baseline serum levels of adiponectin, leptin, 
soluble tumour necrosis factor alpha receptor 2 (sTNFR2) and hsCRP were determined and subjects were followed 
prospectively for 6 years. 
Results: A total of 1785 subjects were included in the final analysis. The cumulative incidence of CVD was 3.4%. At 
baseline, subjects with incident CVD were older, and had higher body mass index (BMI), waist circumference (WC), 
systolic blood pressure (BP), HOMA-IR, and fasting glucose levels (all P<0.001), compared to those who did not 
develop CVD (non-CVD). They also had higher baseline levels of leptin and sTNFR2 (both P<0.001) and hsCRP (median 
[interquartile range], 1.76 [0.87-2.55] mg/L vs 0.69 [0.32-1.49] mg/dL in non-CVD; P<0.001), but similar adiponectin 
levels, compared to non-CVD subjects. Logistic regression showed that baseline hsCRP was an independent predictor 
of CVD (P=0.003) after controlling for the conventional CVD risk factors, and for leptin and sTNFR2. The predictive 
value of leptin or sTNFR2 was not significant after adjustment for conventional CVD risk factors, hsCRP and each 
other. Serum hsCRP levels tertile analysis (<0.45 mg/L, 0.45-1.2 mg/L and >1.2 mg/L) showed that compared to 
subjects in the lowest tertile, those in the highest tertile had an odds ratio of 3.362 for incident CVD (95% CI, 1.249-
9.052; P=0.016). Receiver operating characteristics curve analysis found that an hsCRP level of ≥1 mg/L had the most 
optimal sensitivity and specificity for CVD prediction.
Conclusion: In this 6-year prospective study, hsCRP was an independent predictive factor of CVD in Hong Kong 
Chinese, in addition to conventional CVD risk factors. Measurement of adiponectin and other inflammatory 
biomarkers tested in this study did not provide any adjunctive predictive value. 
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